Zervikale Dystonien

Gerhard Reichel; Christoph Kamm; Jun Suk Kang; Martina Müngersdorf; Sebastian Paus; Iris Reuter; Andrea Stenner; David Weise

doi:10.1055/s-0043-107834

Fortschritte der Neurologie · Psychiatrie, Table of Contents

Fortschr Neurol Psychiatr 2018; 86(06): 368-386
DOI: 10.1055/s-0043-107834

Fort- und Weiterbildung

CME

Zervikale Dystonien

Cervical Dystonia

Gerhard Reichel

,

Christoph Kamm

,

Jun Suk Kang

,

Martina Müngersdorf

,

Sebastian Paus

,

Iris Reuter

,

Andrea Stenner

,

David Weise

Abstract

Zervikale Dystonien sind die häufigsten fokalen Dystonien. Der apparativen Diagnostik müssen eine gründliche allgemeine klinische neurologische Untersuchung und eine exakte phänomenologische Bewertung voran gestellt werden. Bei der Detektion der dystonen Muskeln hilft das Collum-Caput Concept, da nahezu alle Halsmuskeln entweder am Kopf oder an der HWS wirken. Die Behandlung mit Botulinumtoxin ist das therapeutische Mittel der Wahl.

Full Text

References

Literatur
1 Cruchet R. Traité des torticolis spasmodiques. Paris: Mason; 1907 (Volltext: https://archive.org/details/traitdestortic00cruc )
2 Hassler R. , Hrsg. Handbuch der Inneren Medizin. Band 5 Neurologie. Göttingen: Springer; 1953
3 Jankovic J, Adler CH, Charles D. et al. Primary results from the Cervical Dystonia Patient Registry for Observation of Onabotulinumtoxin A Efficacy (CD PROBE). J Neurol Sci 2014; 349: 84-93
4 Comella C, Bhatia K. An international survey of patients with cervical dystonia. J Neurol 2015; 262: 837-848
5 Reichel G. Cervical dystonia: A new phenomenological classification for botulinum toxin therapy. GaBa 2011; 1: 5-12
6 Jahn A. Radiologische Diagnostik bei Zervikaler Dystonie und die Bedeutung für die Therapieplanung mit Botulinumtoxin. Universität Leipzig; 2006
7 Hallett M, Albanese A, Dressler D. et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon 2013; 67: 94-114
8 Albanese A, Asmus F, Bhatia KP. et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 2011; 18 (01) 5-18
9 Jinnah HA, Goodmann E, Rosen AR. et al. Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes. J Neurol 2016; 263: 1188-1194
10 Lehericy S, Tijssen MA, Vidailhet M. et al. The anatomical basis of dystonia: current view using neuroimaging. Mov Disord 2013; 28 (07) 944-957
11 Prudente CN, Hess EJ, Jinnah HA. Dystonia as a network disorder: what is the role of the cerebellum? Neuroscience 2014; 260: 23-35
12 Waddy HM, Fletcher NA, Harding AE. et al. A genetic study of idiopathic focal dystonias. Ann Neurol 1991; 29 (03) 320-324
13 Schmidt A, Jabusch HC, Altenmuller E. et al. Etiology of musician’s dystonia: familial or environmental? Neurology 2009; 72 (14) 1248-1254
14 Leube B, Kessler KR, Goecke T. et al. Frequency of familial inheritance among 488 index patients with idiopathic focal dystonia and clinical variability in a large family. Mov Disord 1997; 12 (06) 1000-1006
15 Leube B, Hendgen T, Kessler KR. et al. Sporadic focal dystonia in northwest Germany: molecular basis on chromosome 18p. Ann Neurol 1997; 42 (01) 111-114
16 Winter P, Kamm C, Biskup S. et al. DYT7 gene locus for cervical dystonia on chromosome 18p is questionable. Mov Disord 2012; 27: 1819-1821
17 Fuchs T, Saunders-Pullman R, Masuho I. et al. Mutations in GNAL cause primary torsion dystonia. Nat Genet 2013; 45: 88-92
18 Charlesworth G, Bhatia KP, Wood NW. The genetics of dystonia: new twists in an old tale. Brain 2013; 136 (07) 2017-2037
19 Balint B, Bhatia KP. Isolated and combined dystonia syndromes - an update on new genes and their phenotypes. Eur J Neurol 2015; 22 (04) 610-617
20 Clarimon J, Asgeirsson H, Singleton A. et al. Torsin A haplotype predisposes to idiopathic dystonia. Ann Neurol 2005; 57 (05) 765-767
21 Kamm C, Asmus F, Mayer P. et al. Strong genetic evidence for association of DYT1 with idiopathic dystonia. Neurology 2006; 67 (10) 1857-1859
22 Sharma N, Franco RA. Jr, Kuster JK. et al. Genetic evidence for an association of the TOR1A locus with segmental/focal dystonia. Mov Disord 2010; 25 (13) 2183-2187
23 Avanzino L, Tinazzi M, Ionta S. et al. Sensory-motor integration in focal dystonia. Neuropsychologia. 2015. ; 79 (B): 288-300
24 Patel N, Jankovic J, Hallett M. Sensory aspects of movement disorders. Lancet Neurol 2014; 13 (01) 100-112
25 Defazio G, Berardelli A, Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain 2007; 130: 1183-1193
26 Breakefield XO, Blood AJ, Li Y. et al. The pathophysiological basis of dystonias. Nat Rev Neurosci 2008; 9: 222-234
27 Colosimo C, Pantano P, Calistri V. et al. Diffusion tensor imaging in primary cervical dystonia. J Neurol Neurosurg Psychiatry 2005; 76 (11) 1591-1593
28 Bonilha L, de Vries PM, Vincent DJ. et al. Structural white matter abnormalities in patients with idiopathic dystonia. Mov Disord 2007; 22 (08) 1110-1116
29 Prell T, Peschel T, Kohler B. et al. Structural brain abnormalities in cervical dystonia. BMC Neurosci 2013; 14: 123
30 Blood AJ, Kuster JK, Woodman SC. et al. Evidence for altered basal ganglia-brainstem connections in cervical dystonia. PLoS One 2012; 7: e31654
31 Reichel G, Stenner A, Jahn A. Zur Phänomenologie der zervikalen Dystonien. Vorschlag einer neuen Behandlungsstrategie mit Botulinumtoxin. Fortschr Neurol Psychiat 2009; 77: 272-277
32 Reichel G. Dystonias oft the Neck: Clinico-Radiologic Correlation. 2012. . In: Rosales RL. (ed). Dystonia – The Many Facets. Rijeka. , Croatia: Intech; 2012. : 17-32
33 Jost WH, Hefter H, Stenner A. et al. Rating scales for cervical dystonia: a critical evaluation of tools for out- come assessment of botulinum toxin therapy. J Neural Transm 2013; 120: 487-496
34 Karch D. Behandlung motorischer Störungen mit manueller Therapie. Stellungnahme der Gesellschaft für Neuropädiatrie. (Memento vom 2. Dezember 2013 im Internet Archive) 2000
35 Wyatt K, Edwards V, Franck L. et al. Cranial osteopathy for children with cerebral palsy: a randomised controlled trial Arch Dis Child 2011; 96 (06) 505-512
36 Cleveland EC, Zampell J, Avraham T. et al. Congenital Mandibular Hypoplasia With Microvascular Free Fibula Flaps in the Pediatric Population: A Paradigm Shift. J Craniofac Surg 2017; 28 (01) 79-83
37 Albanese A, Abbruzzese G, Dressler D. et al. Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement. J Neurol 2015; 262 (10) 2201-2213
38 Charles PD, Manack Adams A, Davis T. et al. Neck Pain and Cervical Dystonia: Treatment Outcomes from CD PROBE. Pain Pract 2016. , doi: 10.1111/papr.12408
39 Flowers JM, Hicklin LA, Marion MH. Anterior and posterior sagittal shift in cervical dystonia: a clinical and electromyographic study, including a new EMG approach of the longus colli muscle. Mov Disord 2011; 26 (13) 2409-2414
40 Fujimoto H, Mezaki T, Yokoe M. et al. Sonographic guidance provides a low-risk approach to the longus colli muscle. Mov Disord 2012; 27 (07) 928-929
41 Herting B, Wunderlich S, Glöckler T. et al. Computed tomographically-controlled injection of botulinum toxin into the longus colli muscle in severe antecollis. Mov Disord 2004; 19 (05) 588-590
42 Reichel G, Stenner A, von Sanden H. et al. Endoscopic-guided injection of botulinum toxin into the longus capitis muscle and into the obliquus superior part of the longus colli muscle in dystonic antecaput: Our experience. Basal Ganglia 2016; 6 (02) 71-114
43 Colosimo C, Tiple D, Berardelli A. Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review. Neurotox Res 2012; 22 (04) 265-273
44 Volkmann J, Mueller J, Deuschl G. et al. DBS study group for dystonia. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol 2014; 13 (09) 875-884
45 De Pauw J, Van der Velden K, Meirte J. The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J Neurol 2014; 261 (10) 1857-1865
46 Viehmann M, Weise D, Brähler E. et al. Complementary/alternative medicine and physiotherapy usage in German cervical dystonia patients. Basal Ganglia 2014; 4: 55-59
47 Chate RA. Int J Oral Maxillofac Surg. Facial scoliosis due to sternocleidomastoid torticollis: a cephalometric analysis . 2004; 33 (04) 338-343
48 Lan Lanzi G, Balottin U, Fazzi E. et al. Benign paroxysmal vertigo of childhood: a long-term follow-up. Cephalalgia 1994; 14: 458-460
49 Spiri A. Pediatric migraine and episodic syndromes that may be associated with migraine. Ital J Pediatr 2014; 40: 92
50 Reichel G, Wissel J. Therapieleitfaden Spastik – Dystonien. 6. Aufl. Bremen: UNI-MED; 2017
51 Bachhuber A, Reichel G, Doberenz M. et al. Botulinum-Toxin-Behandlung - Einfluss von Depression und laufendem Rentenverfahren auf den Therapieerfolg. Nervenarzt 2009; 80: 712-716
52 Skogseid IM, Malt UF, Røislien J. et al. Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia. Eur J Neurol 2007; 14 (10) 1129-1137
53 Brin MF, Comella CL, Jankovic J. et al. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord 2008; 23 (10) 1353-1360
54 Finsterer J, Maeztu C, Revuelta GJ. et al. Collum-caput (COL-CAP) concept for conceptual antecollis, antecaput, and forward sagittal shift. J Neurol Sci 2015; 355 (1–2): 37-43
55 Reichel G, Stenner A, Jahn A. The COL CAP Concept: Optimising the Treatment of Cervical dystonia with Botulinum Toxin: Volume Measurements of M. obliquus capitis inferior in 56 Patients with and 23 without Torticaput. Toxins: 2015: 14.-17 .1.2015, Lisboa;
56 Tatu L, Jost WH. Anatomy and cervical dystonia: „Dysfunction follows form“. J Neural Transm (Vienna) 2017; 124 (02) 237-243